Law ❯ Corporate Law ❯ Securities Regulation ❯ Fraudulent Misrepresentation
Investors face a Jan. 9, 2026 deadline to seek lead-plaintiff status in early-stage securities suits over alleged misstatements tied to SEC and FDA setbacks.